PCM
YCBD icon

Prelude Capital Management’s cbdMD YCBD Stock Holding History

Prelude Capital Management’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5
Closed -$4.77K – 2437
2020
Q2 		$4K Buy
+5
New +$2.24K ﹤0.01% 1757

Other funds holding YCBD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LWM
Lionsbridge Wealth Management Jacksonville Beach, Florida $99.5M AUM 25.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Prelude Capital Management's YCBD Position: Q3 2020 in Review

Prelude Capital Management sold out of cbdMD (YCBD) in Q3 2020, closing a stake of 5 shares — an estimated $4.77K sold.

Prelude Capital Management first reported a position in YCBD in Q2 2020 and held it in 1 quarter. The position peaked at $4K in Q2 2020. 43 funds tracked by Wall St. Rank hold YCBD as of Q3 2020.

  • Prelude Capital Management reported no remaining cbdMD position as of Q3 2020 after selling out during the quarter.
  • Prelude Capital Management sold 5 cbdMD shares in Q3 2020, an estimated $4.77K.
  • Prelude Capital Management first reported a position in cbdMD in Q2 2020 and held it in 1 quarter.
  • Prelude Capital Management's cbdMD position peaked at $4K in Q2 2020.
  • 43 funds tracked by Wall St. Rank held cbdMD as of Q3 2020.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.